Literature DB >> 27341433

Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies.

Jenny L Valentine1, Linxiao Chen1, Emily C Perregaux2, Kevin B Weyant1, Joseph A Rosenthal3, Christian Heiss4, Parastoo Azadi4, Adam C Fisher5, David Putnam6, Gregory R Moe7, Judith H Merritt5, Matthew P DeLisa8.   

Abstract

The development of antibodies against specific glycan epitopes poses a significant challenge due to difficulties obtaining desired glycans at sufficient quantity and purity, and the fact that glycans are usually weakly immunogenic. To address this challenge, we leveraged the potent immunostimulatory activity of bacterial outer membrane vesicles (OMVs) to deliver designer glycan epitopes to the immune system. This approach involved heterologous expression of two clinically important glycans, namely polysialic acid (PSA) and Thomsen-Friedenreich antigen (T antigen) in hypervesiculating strains of non-pathogenic Escherichia coli. The resulting glycOMVs displayed structural mimics of PSA or T antigen on their surfaces, and induced high titers of glycan-specific IgG antibodies following immunization in mice. In the case of PSA glycOMVs, serum antibodies potently killed Neisseria meningitidis serogroup B (MenB), whose outer capsule is PSA, in a serum bactericidal assay. These findings demonstrate the potential of glycOMVs for inducing class-switched, humoral immune responses against glycan antigens.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27341433      PMCID: PMC5116915          DOI: 10.1016/j.chembiol.2016.05.014

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  53 in total

Review 1.  Emerging technologies for making glycan-defined glycoproteins.

Authors:  Lai-Xi Wang; Joseph V Lomino
Journal:  ACS Chem Biol       Date:  2011-12-14       Impact factor: 5.100

2.  Genetic analysis of chromosomal mutations in the polysialic acid gene cluster of Escherichia coli K1.

Authors:  E R Vimr; W Aaronson; R P Silver
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

3.  Bexsero: a multicomponent vaccine for prevention of meningococcal disease.

Authors:  Andrew R Gorringe; Rolando Pajón
Journal:  Hum Vaccin Immunother       Date:  2012-02-01       Impact factor: 3.452

4.  Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.

Authors:  D M Granoff; A Bartoloni; S Ricci; E Gallo; D Rosa; N Ravenscroft; V Guarnieri; R C Seid; A Shan; W R Usinger; S Tan; Y E McHugh; G R Moe
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

Review 5.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 6.  Glycomics: an integrated systems approach to structure-function relationships of glycans.

Authors:  Rahul Raman; S Raguram; Ganesh Venkataraman; James C Paulson; Ram Sasisekharan
Journal:  Nat Methods       Date:  2005-11       Impact factor: 28.547

7.  Efficient preparation of natural and synthetic galactosides with a recombinant beta-1,4-galactosyltransferase-/UDP-4'-gal epimerase fusion protein.

Authors:  O Blixt; J Brown; M J Schur; W Wakarchuk; J C Paulson
Journal:  J Org Chem       Date:  2001-04-06       Impact factor: 4.354

Review 8.  How bacterial carbohydrates influence the adaptive immune system.

Authors:  Fikri Y Avci; Dennis L Kasper
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

9.  Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.

Authors:  Julian Ihssen; Jürgen Haas; Michael Kowarik; Luzia Wiesli; Michael Wacker; Torsten Schwede; Linda Thöny-Meyer
Journal:  Open Biol       Date:  2015-04       Impact factor: 6.411

10.  Determination of carbohydrate structure recognized by prostate-specific F77 monoclonal antibody through expression analysis of glycosyltransferase genes.

Authors:  Motohiro Nonaka; Michiko N Fukuda; Chao Gao; Zhen Li; Hongtao Zhang; Mark I Greene; Donna M Peehl; Ten Feizi; Minoru Fukuda
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

View more
  12 in total

Review 1.  Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli.

Authors:  Christian M Harding; Mario F Feldman
Journal:  Glycobiology       Date:  2019-07-01       Impact factor: 4.313

2.  Bacterial Glycoengineering as a Biosynthetic Route to Customized Glycomolecules.

Authors:  Laura E Yates; Dominic C Mills; Matthew P DeLisa
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.

Authors:  Hannah C Watkins; C Garrett Rappazzo; Jaclyn S Higgins; Xiangjie Sun; Nicole Brock; Annie Chau; Aditya Misra; Joseph P B Cannizzo; Michael R King; Taronna R Maines; Cynthia A Leifer; Gary R Whittaker; Matthew P DeLisa; David Putnam
Journal:  Mol Ther       Date:  2017-02-16       Impact factor: 11.454

Review 4.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

5.  Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.

Authors:  Taylor C Stevenson; Colette Cywes-Bentley; Tyler D Moeller; Kevin B Weyant; David Putnam; Yung-Fu Chang; Bradley D Jones; Gerald B Pier; Matthew P DeLisa
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

6.  Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.

Authors:  Tyler D Moeller; Kevin B Weyant; Matthew P DeLisa
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 7.  Pushing the envelope: LPS modifications and their consequences.

Authors:  Brent W Simpson; M Stephen Trent
Journal:  Nat Rev Microbiol       Date:  2019-07       Impact factor: 60.633

Review 8.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

Review 9.  Bacterial Outer Membrane Vesicles: From Discovery to Applications.

Authors:  Mariana G Sartorio; Evan J Pardue; Mario F Feldman; M Florencia Haurat
Journal:  Annu Rev Microbiol       Date:  2021-08-05       Impact factor: 16.232

10.  Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity.

Authors:  Ralph Pantophlet; Nino Trattnig; Sasha Murrell; Naiomi Lu; Dennis Chau; Caitlin Rempel; Ian A Wilson; Paul Kosma
Journal:  Nat Commun       Date:  2017-11-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.